A physiologically based pharmacokinetic model for arsenic exposure I. Development in hamsters and rabbits

Toxicology and Applied Pharmacology

Volumn 137, Issue 1, 1996, Pages 8-22

  Mann, S ^a   Droz, P O ^a   Vahter, M ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CACODYLIC ACID; METHANEARSONIC ACID;

ANIMAL EXPERIMENT; ARTICLE; FECES; GASTROINTESTINAL TRACT; HAMSTER; KIDNEY; LIVER; LUNG; METABOLITE; MODEL; NONHUMAN; PHARMACOKINETICS; RABBIT; SKIN; TISSUE LEVEL; TOXICOKINETICS; URINARY EXCRETION;

EID: 0029928744     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0052     Document Type: Article

References (47)

1. ACGIH (1993). Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices 1993-1994. Cincinnati.
2. Bates, M. N., Smith, A. H., and Hopenhayn-Rich, C. (1993). Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol. 135, 462-476.
3. Berner, B., and Cooper, E. R. (1985). Models of the skin permeability. In Transdermal Delivery of Drugs (A. F. Kydonieu and B. Berner, Eds.), Vol 2, pp. 41-55. CRC Press, Boca Raton, FL.
4. Buchet, J. P., Lauwerys, R., and Roels, H. (1981). Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenate, monomethylarsonate or dimethylarinsate in man. Int. Arch. Occup. Environ. Health 48, 71-79.
5. Buchet, J. P., and Lauwerys, R. (1985). Study of inorganic methylation by rat liver in vitro: Relevance for interpretation of observations in man. Arch. Toxicol. 57, 125-129.
6. Buchet, J. P., and Lauwerys, R. (1987). Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol. Appl. Pharmacol. 91, 65-74.
7. Buchet, J. P., and Lauwerys, R. (1988). Role of thiols in the in vivo methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 37, 3149-3153.
8. Charbonneau, S. M., Tam, G. K. H., Bryce, F., Zawidzka, Z., and Sandi, E. (1979). Metabolism of orally administered inorganic arsenic in the dog. Toxicol. Lett. 3, 107-113.
9. 74As]arsenic acid in the hamster. Toxicol. Lett. 5, 175-182.
10. Fiserova-Bergerova, V. (1983). Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination, Vol. 2. CRC Press, Boca Raton, FL.
11. Ginsburg, J. M. (1965). Renal mechanism for excretion and transformation of arsenic in the dog. Am. J. Physiol. 208, 832-840.
12. HCP (1978-79). Handbook of Chemistry and Physics, 59th ed. CRC Press, Boca Raton, FL.
13. 74As]arsenic acid in the adult beagle dog. Toxicol. Lett. 4, 7-13.
14. Hopenhayn-Rich, C., Smith, A. H., and Goeden, M. (1993). Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60, 161-177.
15. IARC, International Agency for Research on Cancer (1980). Arsenic and Arsenic Compounds. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, pp. 39-141. Geneva.
16. ICPR (1992). Report of the Task Group on the Reference Man ICPR, Publication No. 23, 5th ed. Pergamon, Elmsford, NY.
17. Johnson, L. R., and Farmer, J. G. (1991). Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure. Bull. Environ. Contam. Toxicol. 46, 53-61.
18. Karasov, W. H., Petrossian, E., Rosenberg, L., and Diamond, J. M. (1986). How do food passage rate and assimilation differ between herbivorous lizards and nonruminant mammals? J. Comp. Physiol. 156, 599-609.
19. Karnasovsky, M. J. (1970). Morphology of capillaries with special reference to capillaries. In Capillary Permeability (C. Crone and N. A. Lassen, Eds.). Alfred Benzon Foundation, Copenhagen.
20. Keele, C. A., and Neil, E. (1971). Samson Wright's Applied Physiology, 12th ed. Oxford Univ. Press, Oxford.
21. Klaassen, C. D. (1974). Biliary excretion of arsenic in rats, rabbits and dogs. Toxicol. Appl. Pharmacol. 29, 447-457.
22. Lerman, S., and Clarkson, T. W. (1983). The metabolism of arsenite and arsenate by the rat. Fundam. Appl. Toxicol. 3, 309-314.
23. Lindstedt, S. L. (1992). International Workshop on Physiologically Based Pharmacokinetic Modeling and Risk Assessment. Fort Collins, CO.
24. Mann, S., Droz, P. O., and Vahter, M. (1996). A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Submitted for publication.
25. 74As)arsenite in mice and rabbits. Chem. Biol. Interact. 50, 49-57.
26. Marafante, E., Vahter, M., and Envall, J. (1985). The role of the methylation in the detoxification of arsenate in the rabbit. Chem. Biol. Interact. 56, 225-238.
27. Marafante, E., and Vahter, M. (1987). solubility, retention and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster. Environ. Res. 42, 72-82.
28. Marafante, E., Vahter, M., Norin, H., Envall, J., Sandström, M., Christakopoulos, A., Ryhage, R. (1987). Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7, 11-117.
29. Odanaka, Y., Matano, O., and Goto, S. (1980). Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bull. Environ. Contam. Toxicol. 24, 452-459.
30. Ruckebusch, Y., Bueno, L., and Fioramont, J. (1981). L'intestin grêle. In La mécanique digestive chez les mammifères, pp. 78. Masson, Paris.
31. Squibb, K. S., and Fowler, B. A. (1983). The toxicity of arsenic and its compounds. In Biological and Environmental Effects of Arsenic: Topics in Environmental Health (B. A. Fowler, Ed.), Vol. 6, pp. 233-269. Elsevier, Amsterdam.
32. Tam, G. K. H., Charbonneau, S. M., Bryce, F., Pomroy, C., and Sandy, E. (1979). Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50, 319-322.
33. Vahter, M. (1981). Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res. 25, 286-293.
34. Vahter, M., Marafante, E., Lindgren, A., and Decker, L. (1982). Tissue distribution and subcellular binding of arsenic in marmoset monkeys after injection of 74-As-arsenite. Arch. Toxicol. 51, 65-77.
35. Vahter, M., and Envall, J. (1983). In vivo reduction of arsenate in mice and rabbits. Environ. Res. 32, 14-24.
36. Vahter, m., and Marafante, E. (1983). Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact. 47, 29-44.
37. 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 13, 259-264.
38. Vahter, M., and Marafante, E. (1985). Reduction and binding of arsenate in marmoset monkeys. Arch. Toxicol. 57, 119-124.
39. Vahter, M. (1986). Environmental and occupational exposure to inorganic arsenic. Acta Pharm. Tox. (Suppl.) 59, 31-34.
40. Vahter, M., and Marafante, E. (1988). In vivo methylation and detoxification of arsenic. In The Biological Alkylation of Heavy Elements (P. J. Craig and F. Glockling, Eds.), pp. 105-119. Royal Society of Chemistry, London.
41. Vahter, M., and Marafante, E. (1993). Metabolism of alkyl arsenic and antimony compounds. In Metal Ions in Biological Systems (H. Sigel and A. Sigel, Eds.), Vol. 29. Decker, NY.
42. Vahter, M. (1994). Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 32, 14-24.
43. Vahter, M., Couch, R., Nermell, B., and Nilsson, R. (1995). Unlike most other mammals, the chimpanzee does not methylate inorganic arsenic. Toxicol. Appl. Pharmacol., in press.
44. WHO, World Health Organization (1981). Environmental Health Criteria 18 - Arsenic. International Programme on Chemical Safety, Geneva.
45. Yamauchi, H., and Yamamura, Y. (1979). Dynamic change of inorganic arsenic and methylarsenic compounds in human urine after oral intake as arsenic trioxide. Ind. Health. 17, 79-83.
46. Yamauchi, H., and Yamamura, Y. (1984). Metabolism and excretion of orally administered dimethylarsinic acid in the ahmter. Toxicol. Appl. Pharmacol. 74, 134-140.
47. Yamauchi, H., and Yamamura, Y. (1985). Metabolism and excretion of orally administered arsenic trioxide in the hamster. Toxicology 34, 113-121.